Lilly Diabetes launches mobile app to support Type 1 diabetes patients

INDIANPOLIS — Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

The Lilly Glucagon mobile app is an interactive tool designed to teach caregivers how to use severe hypoglycemia treatment Glucagon (1-mg) for injection through simulated practice, thus helping caregivers better understand Glucagon's role in diabetes management. The Lilly Glucagon mobile app includes:

• 
  

  Information about severe hypoglycemia and Glucagon;

  
  


• 
  

  Simulated practice demonstrating how to prepare and inject Glucagon;

  
  


• 
  

  Visual and audio emergency instructions;

  
  


• 
  

  Tools to keep track of kit locations and alerts for expiration dates; and

  
  


• 
  

  Important safety information.

  
  

"Lilly Diabetes is committed to developing personalized solutions to help people with diabetes achieve their treatment goals and improve their outcomes," said Matt Caffrey, U.S. product brand director of marketing specialty for Lilly Diabetes. "The Lilly Glucagon mobile app leverages the power and reach of mobile technology, providing another opportunity to support people living with Type 1 diabetes. Lilly Diabetes is constantly striving to create new and better tools to support the diabetes community in a variety of ways."

The Lilly Glucagon mobile app now is available on the iTunes store as a free download for iPhone or iPad mobile devices.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.